BACKGROUND: There are emerging data that simultaneous pancreas-kidney transplant (SPK) prolongs life compared with kidney transplant alone (KTA) in type 1 diabetics with end-stage renal disease. This study was a retrospective comparison of SPK with KTA in patients with type 1 diabetes. METHODS: Between 1 January 1992 and 30 April 2002, 101 patients with type 1 diabetes were transplanted. Fifty-one of these patients received a KTA and 50 had a SPK. All patients underwent coronary angiography with surgical correction of any coronary artery disease before being listed. All patients who underwent SPK received quadruple immunosuppressive therapy consisting of antilymphocyte globulin, calcineurin inhibitor (tacrolimus or cyclosporin), azathioprine and steroids. Those who underwent KTA received calcineurin inhibitor (tacrolimus or cyclosporin), azathioprine and steroids. RESULTS: Patient survival at 1, 3, 5 and 8 years was 96, 93, 89 and 77 per cent respectively after SPK, and 93, 75, 57 and 47 per cent respectively after KTA (P = 0.018 at 8 years). CONCLUSION: The addition of pancreatic transplantation prolongs life in type 1 diabetic patients with renal failure compared with renal transplantation alone. Copyright 2003 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
BACKGROUND: There are emerging data that simultaneous pancreas-kidney transplant (SPK) prolongs life compared with kidney transplant alone (KTA) in type 1 diabetics with end-stage renal disease. This study was a retrospective comparison of SPK with KTA in patients with type 1 diabetes. METHODS: Between 1 January 1992 and 30 April 2002, 101 patients with type 1 diabetes were transplanted. Fifty-one of these patients received a KTA and 50 had a SPK. All patients underwent coronary angiography with surgical correction of any coronary artery disease before being listed. All patients who underwent SPK received quadruple immunosuppressive therapy consisting of antilymphocyte globulin, calcineurin inhibitor (tacrolimus or cyclosporin), azathioprine and steroids. Those who underwent KTA received calcineurin inhibitor (tacrolimus or cyclosporin), azathioprine and steroids. RESULTS:Patient survival at 1, 3, 5 and 8 years was 96, 93, 89 and 77 per cent respectively after SPK, and 93, 75, 57 and 47 per cent respectively after KTA (P = 0.018 at 8 years). CONCLUSION: The addition of pancreatic transplantation prolongs life in type 1 diabeticpatients with renal failure compared with renal transplantation alone. Copyright 2003 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
Authors: Marcus Salvatori; Ravi Katari; Timil Patel; Andrea Peloso; Jon Mugweru; Kofi Owusu; Giuseppe Orlando Journal: J Diabetes Sci Technol Date: 2014-01-01
Authors: J P Lindahl; A Hartmann; R Horneland; H Holdaas; A V Reisæter; K Midtvedt; T Leivestad; O Oyen; T Jenssen Journal: Diabetologia Date: 2013-04-03 Impact factor: 10.122
Authors: Sayed-Hadi Mirmalek-Sani; Giuseppe Orlando; John P McQuilling; Rajesh Pareta; David L Mack; Marcus Salvatori; Alan C Farney; Robert J Stratta; Anthony Atala; Emmanuel C Opara; Shay Soker Journal: Biomaterials Date: 2013-04-10 Impact factor: 12.479
Authors: Maura Rossetti; Giorgina B Piccoli; Manuel Burdese; Cesare Guarena; Roberta Giraudi; Elisabetta Mezza; Valentina Consiglio; Giorgio Soragna; Maria Messina; Giuseppe P Segoloni Journal: Rev Diabet Stud Date: 2004-11-10
Authors: Paolo R Salvalaggio; Nino Dzebisashvili; Brett Pinsky; Mark A Schnitzler; Thomas E Burroughs; Ralph Graff; David A Axelrod; Daniel C Brennan; Krista L Lentine Journal: Diabetes Care Date: 2009-01-08 Impact factor: 17.152
Authors: Uwe Scheuermann; Sebastian Rademacher; Nora Jahn; Elisabeth Sucher; Daniel Seehofer; Robert Sucher; Hans-Michael Hau Journal: Health Qual Life Outcomes Date: 2020-09-10 Impact factor: 3.186